Study Evaluating Whether the Bispectral Index Prevents Patients at Higher Risk From Being Awake During Surgery and Anesthesia (BAG-RECALL)

January 3, 2011 updated by: Washington University School of Medicine

BAG-RECALL Study: BIS or Anesthesia Gas to Reduce Explicit Recall

The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able to measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.

Study Overview

Detailed Description

The incidence of anesthesia awareness (AA) is 0.1-0.2% and may result in post traumatic stress disorders. For some patients, owing to illness, medications, substance misuse or surgery, the risk approaches 1%. The B-AWARE Study by Myles et al. suggested that the bispectral index (BIS) monitor, which reportedly reflects anesthetic depth, may decrease the incidence of AA in higher risk patients by 82%. The American Society of Anesthesiologists has published a practice advisory on AA, which does not recommend the routine use of cerebral function monitors. We propose to test the hypothesis that an anesthetic protocol based on BIS decreases the incidence of AA among higher risk patients compared with an anesthetic protocol based on the end-tidal anesthetic gas (ETAG) concentration. We have completed a randomized, single-blinded prospective feasibility study (The B-Unaware Trial) which enrolled 2000 patients at higher risk for AA. Four patients (0.21%; 95% CI=0.06% to 0.57%) had definite AA, of whom two were in the BIS-guided group and two in the ETAG-guided group. Nine patients (0.46%; 95% CI=0.22% to 0.91%) had definite or possible AA, of whom six were in the BIS-guided group and three in the ETAG-guided group. The BAG RECALL study will be a multi-center, prospective, single-blinded, randomized study enrolling 6000 patients at higher risk for AA. The BAG RECALL study is adequately powered and rigorously designed to answer with a reasonable degree of scientific probability whether BIS guidance results in clinically relevant reduction in anesthesia awareness among higher risk patients undergoing general anesthesia.

At the University of Michigan, a parallel study will be conducted - Michigan Awareness Control Study, MACS (NCT00689091) - enrolling 30,000 patients to assess whether the BIS monitor decreases the likelihood of anesthesia awareness among all patients undergoing general anesthesia, regardless of their risk profile. The investigators of this study and the BAG-RECALL study have collaborated in designing these studies and are pre-specifying that common outcome measures will be examined collaboratively including data from both studies.

Study Type

Interventional

Enrollment (Anticipated)

6000

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Manitoba
      • Winnipeg, Manitoba, Canada
        • University of Manitoba
    • Illinois
      • Chicago, Illinois, United States
        • University Of Chicago
    • Missouri
      • St Louis, Missouri, United States, 63110
        • Washington University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

MUST HAVE:

General Anesthesia with volatile anesthetic

PATIENT CHARACTERISTICS

Major Criteria (Must have any 1 of the following:)

  1. Planned open heart surgery
  2. Medications - anticonvulsants, abuse of opiates, benzodiazepines, cocaine
  3. EF<40%
  4. Prior history of awareness (recall)
  5. History of difficult intubation or anticipated difficult intubation
  6. ASA IV or V status
  7. Aortic stenosis
  8. End stage lung disease
  9. Marginal exercise tolerance not secondary to musculoskeletal dysfunction
  10. Pulmonary hypertension
  11. Daily alcohol consumption

Exclusion Criteria:

  1. Surgical procedure that prevents the use of the BIS (e.g. surgery of forehead)
  2. Patient positioning prevents use of the BIS
  3. Surgery with wake-up test.
  4. Less than 18 years of age
  5. Vulnerable populations, such as those with dementia and those unable to provide informed consent.
  6. Stroke with residual neurological deficits

    -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: 1
Bispectral index-guided protocol
Aim to titrate anesthesia to maintain BIS between 40 and 60.
ACTIVE_COMPARATOR: 2
End-tidal anesthetic gas-guided protocol
Aim to maintain anesthetic gas between 0.7 and 1.3 MAC equivalents

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The incidence of explicit recall of events during the surgical and anesthetic periods.
Time Frame: Three years
Three years

Secondary Outcome Measures

Outcome Measure
Time Frame
Meta-analysis for anesthesia awareness incorporating higher risk patients from the completed B-Unaware Trial (NCT00281489), the BAG-RECALL Trial, and the Michigan Awareness Control Study (MACS)(NCT00689091).
Time Frame: Three years
Three years
Incidence of post-traumatic stress disorder (PTSD).
Time Frame: Five years
Five years
Association between type of awareness event and PTSD, and whether the PTSD is associated with late reporting (30 days) of awareness.
Time Frame: 5 years
5 years
Types of dreams and their relationship to BIS and ETAG.
Time Frame: Three years
Three years
The relationship between deep hypnotic time, anesthetic dose (MAC), mean arterial pressure, and end tidal carbon dioxide, and early (one-month) and late (one-year) mortality.
Time Frame: Four years
Four years
Relationship between BIS, heart rate and blood pressure.
Time Frame: Three years
Three years
Relationship between BIS and anesthesia dose and concentration.
Time Frame: Three years
Three years
Association between baseline BIS values, patient health and early (one-month) and late (one-year) mortality.
Time Frame: Four years
Four years
Interaction between hemispheric dominance and BIS.
Time Frame: Three years
Three years
Effect of red hair phenotypes on the relationship between ETAG and BIS.
Time Frame: Three years
Three years
Refinement of risk factors for anesthesia awareness.
Time Frame: Three years
Three years
Relationship between rising BIS in the PACU and first memory after surgery.
Time Frame: Three years
Three years
Postoperative delirium.
Time Frame: Three years
Three years
BIS and mixed venous saturation.
Time Frame: Three years
Three years
Induction of anesthesia and hypotension.
Time Frame: Three years
Three years
Incidence of postoperative nausea and vomiting.
Time Frame: Three years
Three years
Incidence of and severity of postoperative pain.
Time Frame: Three years
Three years
Effect of BIS and ETAG protocols on time to open eyes, time to extubation, and time spent in the postoperative recovery unit.
Time Frame: Three years
Three years
Effect of a defasciculating dose of a non-depolarizing muscle relaxant on BIS.
Time Frame: Three years
Three years
The effect of patient temperature on BIS.
Time Frame: Three years
Three years
Incidence of recall of traveling to the OR among patients who receive midazolam in the holding area and whose initial BIS reading in the OR is > 60.
Time Frame: Three years
Three years
Relationship between BIS, ETAG and EEG parameters.
Time Frame: Three years
Three years
Annual assessment of practitioners' abilities to interpret BIS tracings and to identify artefacts.
Time Frame: Three years
Three years
Differences in anesthesia practice among four institutions in the USA and Canada as judged by anesthetic doses and BIS readings.
Time Frame: Three years
Three years
Effect of BIS and ETAG protocols on anesthetic dose administration and on BIS readings.
Time Frame: Three years
Three years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael S Avidan, MBBCh FCA, Washington University School of Medicine
  • Study Director: David Glick, MD, University Of Chicago
  • Study Chair: Eric Jacobsohn, MBChB, University of Manitoba
  • Study Director: Michael O'Connor, MD, University Of Chicago

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2008

Primary Completion (ACTUAL)

December 1, 2010

Study Registration Dates

First Submitted

May 16, 2008

First Submitted That Met QC Criteria

May 21, 2008

First Posted (ESTIMATE)

May 22, 2008

Study Record Updates

Last Update Posted (ESTIMATE)

January 4, 2011

Last Update Submitted That Met QC Criteria

January 3, 2011

Last Verified

January 1, 2011

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe